Adenoviral-mediated gene transferinto the canine brain in vivo: Commentary

Marianela Candolfi, E. Antonio Chiocca, Kurt Kroeger, G. Elizabeth Pluhar, Josee Bergeron, Mariana Puntel, James Curtin, Elizabeth A. McNiel, Andrew B. Freese, John R. Ohlfest, Peter Moore, Pedro R. Lowenstein, Maria G. Castro

Research output: Contribution to journalComment/debate

Abstract

Glioblastoma multiforme (GBM) is a devastating brain tumor for which there is no cure. Adenoviral-mediated transfer of conditional cytotoxic (herpes simplex virus [HSV] 1-derived thymidine kinase [TK]) and immunostimulatory (Fms-like tyrosine kinase 3 ligand [Flt3L]) transgenes elicited immune-mediated long-term survival in a syngeneic intracranial GBM model in rodents. However, the lack of a large GBM animal model makes it difficult to predict the outcome of therapies in humans. Dogs develop spontaneous GBM that closely resemble the human disease; therefore, they constitute an excellent large animal model. We assayed the transduction efficiency of adenoviral vectors (Ads) encoding β-galactosidase (βGal), TK, and Flt3L in J3T dog GBM cells in vitro and in the dog brain in vivo.
Original languageEnglish
Pages (from-to)178
Number of pages1
JournalNeurosurgery
Volume60
Issue number1
DOIs
Publication statusPublished - Jan 2007
Externally publishedYes

Fingerprint

Dive into the research topics of 'Adenoviral-mediated gene transferinto the canine brain in vivo: Commentary'. Together they form a unique fingerprint.

Cite this